These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8092154)
41. [The drug commission of German physicians and phase IV screening]. Ochsenfahrt H MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498 [No Abstract] [Full Text] [Related]
43. [Drug committees in Denmark. Status and future challenges]. Rabøl R; Kampmann JP; Christensen HR Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009 [No Abstract] [Full Text] [Related]
44. Correct utilization and management of peripherally inserted central catheters and midline catheters in the alternate care setting. Carlson KR J Intraven Nurs; 1999; 22(6 Suppl):S46-50. PubMed ID: 10865608 [TBL] [Abstract][Full Text] [Related]
45. Patient drug safety requires P and T attention to these guidelines. Myers RS Mod Hosp; 1968 Nov; 111(5):104 passim. PubMed ID: 5712126 [No Abstract] [Full Text] [Related]
46. [Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences]. Müller-Oerlinghausen B Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):606-10. PubMed ID: 9527451 [TBL] [Abstract][Full Text] [Related]
47. The peripheral intravenous catheter: an appropriate yet often overlooked choice for venous access. Gorski LA Home Healthc Nurse; 2009 Feb; 27(2):130-2. PubMed ID: 19212229 [No Abstract] [Full Text] [Related]
49. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society]. Homann G Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792 [No Abstract] [Full Text] [Related]
50. Development of ASHP therapeutic guidelines. Dotson LR; Witmer DR Am J Health Syst Pharm; 1995 Feb; 52(3):254-5. PubMed ID: 7749951 [No Abstract] [Full Text] [Related]
56. [Drug supply report and expert pronouncement]. Rosén A Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469312 [No Abstract] [Full Text] [Related]
57. [Create or strengthen the drug committee at a hospital]. Bruneton C Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023 [TBL] [Abstract][Full Text] [Related]
58. ASHP national survey of hospital-based pharmaceutical services--1992. Crawford SY; Myers CE Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870 [TBL] [Abstract][Full Text] [Related]
59. [Work of the committee on drug side effects]. Naes K Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664 [No Abstract] [Full Text] [Related]
60. [Registration of adverse effects in drug therapy]. Skobba TJ Tidsskr Nor Laegeforen; 1970 Jan; 90(1):6-9. PubMed ID: 5426192 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]